Class Action Concerning the Drug Fosamax for ONJ (osteonecrosis of the jaw)

Class action description

Class action against Merck Frost because of the risks associated with taking the drug and for having failed in its duty to provide information to consumers.

Group description

The consumers of the drug FOSAMAX and their families for the damages incurred.

Chronology

– May 2007: Motion for authorization to institute a class action :
– November 2007: Amendment to the Motion for authorization to institute a class action;
– April 2008: Judgment authorizing the amendment of the Motion for authorization to institute a class action
– March 2009: Re-amendment to the Motion for authorization to institute a class action;
– June 2009: Judgment authorizing the re-amendment of the Motion for authorization to institute a class action
– July 4th 2011: Judgment dismissing the motion for authorization to institute a class action.
– July 26th 2011: Inscription in appeal of the judgment dismissing the authorization.
– January 16th 2013: Judgment dismissing the appeal.

Notices and News

Notice to Members - Fosamax and Fosavance Drugs

2017/04/14
Notice of approval of settlement of FOSAMAX/FOSAVANCE litigation.
Pierre Sylvestre
Lawyers assigned to the dossier

Are you a member?

Do you have a class action in mind?

How can we help?